Cetera Investment Advisers Buys 595 Shares of Genpact Limited (NYSE:G)

Cetera Investment Advisers lifted its stake in shares of Genpact Limited (NYSE:G) by 4.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 13,269 shares of the business services provider’s stock after purchasing an additional 595 shares during the period. Cetera Investment Advisers’ holdings in Genpact were worth $570,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in G. Vanguard Group Inc. raised its stake in Genpact by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 16,962,496 shares of the business services provider’s stock valued at $728,539,000 after acquiring an additional 61,376 shares during the period. Victory Capital Management Inc. raised its stake in Genpact by 18.1% in the 4th quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider’s stock valued at $423,205,000 after acquiring an additional 1,511,790 shares during the period. Franklin Resources Inc. raised its stake in Genpact by 1.3% in the 4th quarter. Franklin Resources Inc. now owns 4,203,956 shares of the business services provider’s stock valued at $180,560,000 after acquiring an additional 55,771 shares during the period. Dimensional Fund Advisors LP increased its position in Genpact by 5.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,848,449 shares of the business services provider’s stock worth $165,288,000 after buying an additional 208,759 shares during the period. Finally, Geode Capital Management LLC increased its position in Genpact by 3.6% during the 4th quarter. Geode Capital Management LLC now owns 3,825,344 shares of the business services provider’s stock worth $170,175,000 after buying an additional 133,938 shares during the period. Institutional investors own 96.03% of the company’s stock.

Insider Activity at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. This trade represents a 4.20% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Nicholas C. Gangestad acquired 2,000 shares of the stock in a transaction dated Tuesday, May 13th. The shares were bought at an average price of $43.97 per share, with a total value of $87,940.00. Following the completion of the transaction, the director now directly owns 2,000 shares of the company’s stock, valued at $87,940. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.07% of the stock is currently owned by insiders.

Genpact Stock Performance

G opened at $43.50 on Tuesday. The business’s fifty day moving average is $47.26 and its 200-day moving average is $47.38. The firm has a market cap of $7.61 billion, a P/E ratio of 15.32, a price-to-earnings-growth ratio of 1.84 and a beta of 1.02. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76.

Genpact (NYSE:G) last released its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. The business had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. Genpact had a return on equity of 22.50% and a net margin of 10.77%. Genpact’s revenue was up 7.4% compared to the same quarter last year. During the same period last year, the firm posted $0.73 earnings per share. Sell-side analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on G shares. Robert W. Baird lowered their price objective on Genpact from $56.00 to $50.00 and set a “neutral” rating on the stock in a research report on Thursday, May 8th. Mizuho increased their target price on Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a report on Monday, February 10th. TD Cowen raised Genpact from a “hold” rating to a “buy” rating and increased their target price for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Needham & Company LLC reduced their target price on Genpact from $55.00 to $50.00 and set a “buy” rating on the stock in a report on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $50.71.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.